Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands

BACKGROUND: The 10-year overall survival with adjuvant hepatic arterial infusion pump (HAIP) chemotherapy after resection of colorectal liver metastases (CRLMs) was 61% in clinical trials from Memorial Sloan Kettering Cancer Center. A pilot study was performed to evaluate the safety and feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Buisman, Florian E., Grünhagen, Dirk J., Homs, Marjolein Y. V., Grootscholten, Cecile, Filipe, Wills F., Kemeny, Nancy E., Cercek, Andrea, D’Angelica, Micheal I., Donswijk, Maarten L., van Doorn, Leni, Emmering, Jasper, Jarnagin, William R., Kingham, T. Peter, Klompenhouwer, Elisabeth G., Kok, Niels F. M., Kuiper, Maria C., Moelker, Adriaan, Prevoo, Warner, Versleijen, Michelle W. J., Verhoef, Cornelis, Kuhlmann, Koert F. D., Groot Koerkamp, Bas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Hepatobiliary Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863781/
https://www.ncbi.nlm.nih.gov/pubmed/31641947
http://dx.doi.org/10.1245/s10434-019-07973-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863781/
https://www.ncbi.nlm.nih.gov/pubmed/31641947
http://dx.doi.org/10.1245/s10434-019-07973-w

Ejemplares similares